MIRA Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
MIRA Pharmaceuticals has a total shareholder equity of $3.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.3M and $692.8K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.14m |
| Equity | US$3.57m |
| Total liabilities | US$692.83k |
| Total assets | US$4.27m |
Financial Position Analysis
Short Term Liabilities: MIRA's short term assets ($4.2M) exceed its short term liabilities ($692.8K).
Long Term Liabilities: MIRA has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: MIRA is debt free.
Reducing Debt: MIRA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MIRA has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: MIRA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29.9% each year